Syncing versus linking: A patient’s clinical trial journey
As precision medicines and highly individualized therapies become more common, patients are...
As precision medicines and highly individualized therapies become more common, patients are...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists trea...